Hospira Inc. is recalling 164,860 units of Naloxone Hydrochloride Injection, a medication used to reverse opioid overdoses. The recall was initiated because particulate matter (physical contaminants) was discovered on the syringe plungers. These affected syringes were distributed nationwide across the United States, Puerto Rico, and Guam.
The presence of particulate matter on the syringe plunger can contaminate the medication during administration. If injected, this could lead to local swelling, irritation of the blood vessels, or more serious complications like an embolism if the particles travel through the bloodstream.
Drug recall refund and guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.